Literature DB >> 33758112

Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists.

Ashish P Thakrar1, Lindsay Jablonski, Jessica Ratner, Darius A Rastegar.   

Abstract

For patients with opioid use disorder transitioning from methadone or requiring opioid analgesia, initiating buprenorphine for opioid use disorder can be difficult because of the risk of precipitated withdrawal. Low-dose initiation, also known as micro-dosing, is an alternative to standard initiation. Prior studies relied on nonstandard dosing of tablets or films, patches, or buccal formulations, all of which are unavailable in many hospitals. We report a novel approach to micro-dosing using intravenous buprenorphine. Two patients, one on methadone maintenance and another requiring postoperative opioid analgesia, were transitioned to buprenorphine with concurrent full-agonist opioids and without precipitated withdrawal.
Copyright © 2021 American Society of Addiction Medicine.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 33758112     DOI: 10.1097/ADM.0000000000000838

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  2 in total

1.  Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl.

Authors:  Neil B Varshneya; Ashish P Thakrar; J Gregory Hobelmann; Kelly E Dunn; Andrew S Huhn
Journal:  J Addict Med       Date:  2021-11-23       Impact factor: 4.647

Review 2.  Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review.

Authors:  Lauren A Spreen; Emma N Dittmar; Kyle C Quirk; Michael A Smith
Journal:  Pharmacotherapy       Date:  2022-03-25       Impact factor: 6.251

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.